About Infugen
Infugen is a Healthcare company based in Mumbai (India) founded in 2004. Exporting of pharmaceutical formulations and medical devices is conducted by Infugen in the healthcare sector. Its Indian entity Infugen Pharma Private Limited reported revenue of ₹29.66 Cr. Infugen offers products and services including Pharmaceutical Formulations and Medical Devices. Its focus areas include Pharmaceuticals, Formulations, Manufacturing and Medical Devices.
Company details
Infugen is recognized as a WHO GMP certified export house that specializes in pharmaceutical formulations, including oncology drugs and IV infusions, with products registered in over 20 countries. Support is provided to global partners in regions like Africa, Asia, and the Americas, focusing on affordable and accessible healthcare solutions. The company has been established since 1999 and maintains a capacity for large-scale production, such as tablets and capsules, while emphasizing compliance and partnerships to bridge gaps in global healthcare access. Its operations are based in India and Canada, ensuring reliable manufacturing and distribution practices are followed.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website infugenpharma.com
- Social LinkedIn
- Legal Name Infugen Pharma Pvt. Ltd
- Date of Incorporation 04 Feb, 1999
- Jurisdiction Sangli, Maharashtra, India
- Annual Revenue₹29.66 Cr
FY 2025 · -21% YoY
- Net Profit₹60.9 Lakh
FY 2025 · 2% margin
- EBITDA₹1.78 Cr
FY 2025 · 6% margin
Associated legal entities of Infugen
Infugen operates through Infugen Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Infugen Pharma Private Limited CIN U24231PN1999PTC013295 | Active | 04 Feb 1999 | Sangli, Maharashtra | ₹29.7 Cr | 2 | View details |
Products & Services of Infugen
Infugen offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Medical Devices.
Various formulations such as oral solids, liquids, IV infusions, and oncology drugs are manufactured and exported by Infugen.
Surgical and medical disposables are supplied by Infugen for use in healthcare settings.
Board of directors of Infugen Pharma Private Limited (Infugen)
Infugen Pharma Private Limited is the primary company behind Infugen. The board of Infugen Pharma Private Limited currently have 2 directors; the longest-serving is Sandeep Jagjeevan Modi, appointed in 1999.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandeep Jagjeevan Modi DIN 01274836 | Director | 04 Feb 1999 | 27 yrs 9 mo | Infugen Pharma Private Limited |
| Bharat Jagjivan Bhate DIN 00896988 | Director | 04 Feb 1999 | 27 yrs 9 mo | Infugen Pharma Private Limited |
Financials of Infugen
Figures of Infugen Pharma Private Limited, the primary company behind Infugen, for FY 2025. Revenue was ₹29.66 Cr (-21% year on year). Net profit was ₹60.9 Lakh (2% margin). EBITDA was ₹1.78 Cr (6% margin). Revenue has grown at a compounded annual rate of -2% over three years and +21% over five years.
- ₹29.66 CrRevenue · FY 2025 · -21% YoY
- ₹60.9 LakhNet profit · 2% margin
- ₹1.78 CrEBITDA · 6% margin
- ₹10 LakhPaid-up capital
- -2%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Infugen Pharma Private Limited are on its company page.
Detailed financial statements for Infugen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Infugen
Infugen was founded in 2004.
Infugen is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Infugen, Infugen Pharma Private Limited, reported revenue of ₹29.66 Cr for FY 2025, down 21% year on year.
Infugen is recognized as a WHO GMP certified export house that specializes in pharmaceutical formulations, including oncology drugs and IV infusions, with products registered in over 20 countries. Support is provided to global partners in regions like Africa, Asia, and the Americas, focusing on affordable and accessible healthcare solutions. The company has been established since 1999 and maintains a capacity for large-scale production, such as tablets and capsules, while emphasizing compliance and partnerships to bridge gaps in global healthcare access. Its operations are based in India and Canada, ensuring reliable manufacturing and distribution practices are followed.
Infugen offers Pharmaceutical Formulations and Medical Devices.
Infugen operates through Infugen Pharma Private Limited.
The legal entities of Infugen currently have 2 directors, including Sandeep Jagjeevan Modi, Bharat Jagjivan Bhate.